Developmental Core B
发展核心B
基本信息
- 批准号:10397170
- 负责人:
- 金额:$ 178.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-23 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAreaAwardBasic ScienceBiomedical ResearchBiostatistics CoreBudgetsCOVID-19 pandemicClinicalCollaborationsCommunicable DiseasesCommunitiesDevelopmentDiscipline of NursingEducational workshopEnvironmentFacultyFosteringFundingFunding OpportunitiesGrantGroup MeetingsGrowthHIVHealthHealth SciencesHomeInfectionInfrastructureInstitutionInterest GroupInvestmentsKnowledgeLettersLinkMedicalMedicineMentorsMissionModelingOutcomeOutcome MeasurePeer ReviewPersonsPilot ProjectsProcessPublic HealthPublicationsResearchResearch InstituteResearch PersonnelResearch PriorityResearch Project GrantsResourcesRestReview CommitteeSeriesServicesSouth TexasStudentsSystemTexasUnited States National Institutes of HealthUniversitiesWorkWritingbiomedical informaticscareercareer developmentco-infectioncollegecomorbidityinnovationinterestmemberpeerpeer coachingprogramsresponsesubstance usesymposiumworking group
项目摘要
PROJECT SUMMARY
The Texas D-CFAR Developmental Core B will foster the development of HIV-related research at Baylor
College of Medicine (Baylor), University of Texas Health Science Center at Houston (UTHealth), and the Texas
Biomedical Research Institute (TxBiomed) through investigator-initiated pilot project awards, career
development mentoring, and support services for HIV investigators. Pilot project applications will be solicited in
high-priority areas of HIV research. Applications will undergo rigorous peer review modeled after the NIH
system. Pilot grant outcomes (e.g., publications, subsequent external funding) will be tracked for a minimum of
5 years. Developmental Core B will also support the Substance Use Scientific Working Group (SU-SWG) that
addresses a critical research topic for people with HIV (PWH) in Texas. Developmental Core B will facilitate
high priority areas of HIV research and SWG-targeted pilot project cycles, supplemented with generous
institutional funds provided by Baylor, UTHealth, and TxBiomed. Infrastructure provided by Core B will also
enable the D-CFAR to respond to NIH supplement opportunities. Developmental Core B will offer a uniquely
comprehensive and proactive mentoring program focused on junior investigators applying for pilot project
funding. A required Letter-of-Intent process will link junior investigators with a research mentor early in the pilot
project grant writing process. The mentoring program will then facilitate the assembly of a mentor team
consisting of three mentors—research, peer, and career—for each junior investigator applying for pilot project
funding. Innovative plans will extend mentoring from the pilot award through the first NIH grant. Developmental
Core B will sponsor an HIV Research Group meeting (HRGM) series, an AIDS Research Forum (ARF) series,
and a Workshop in HIV series. Core B will also sponsor an Annual Texas D-CFAR Conference where HIV
researchers throughout Texas will present their research, allowing investigators to receive critical input and
establish new collaborations.
项目摘要
德克萨斯州D-CFAR发展核心B将促进贝勒大学艾滋病毒相关研究的发展
医学院(贝勒),得克萨斯大学休斯顿健康科学中心(UTHealth)和得克萨斯州
生物医学研究所(TxBiomed)通过赞助商发起的试点项目奖,职业生涯
发展指导和艾滋病毒调查人员的支助服务。试验计划的申请将于
艾滋病研究的优先领域。申请将经过严格的同行审查仿照美国国立卫生研究院
系统试点赠款成果(例如,出版物,随后的外部资金)将被跟踪至少
5年发展核心B还将支持物质使用科学工作组(SU-SWG),
针对德克萨斯州艾滋病毒感染者(PWH)的一个关键研究课题。发展核心B将促进
艾滋病毒研究的高度优先领域和以工作组为目标的试点项目周期,
由Baylor,UTHealth和TxBiomed提供的机构资金。核心B提供的基础架构还将
使D-CFAR能够响应NIH补充机会。发展核心B将提供一个独特的
针对申请试点项目的初级调查员的全面和积极的辅导方案
经费在试点初期,一份必要的意向书流程将把初级研究人员与研究导师联系起来
项目赠款写作过程。然后,指导计划将促进指导小组的组建
由三名导师组成-研究,同行和职业-为每个申请试点项目的初级研究员
经费创新计划将通过第一个NIH赠款从试点奖励中扩展指导。发育
核心B将赞助艾滋病毒研究小组会议系列、艾滋病研究论坛系列,
以及艾滋病系列研讨会。核心B还将赞助年度德克萨斯州D-CFAR会议,
德克萨斯州的研究人员将展示他们的研究,使研究人员能够获得关键的输入,
建立新的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew P Rice其他文献
Andrew P Rice的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew P Rice', 18)}}的其他基金
Imaging-base Automated Screen for Compounds that Induce P-TEFb
基于成像的自动筛选诱导 P-TEFb 的化合物
- 批准号:
9352533 - 财政年份:2017
- 资助金额:
$ 178.53万 - 项目类别:
Role of NEAT1 lncRNA in HIV replication
NEAT1 lncRNA 在 HIV 复制中的作用
- 批准号:
9292251 - 财政年份:2016
- 资助金额:
$ 178.53万 - 项目类别:
Mechanisms of Action of Novel HIV Rev Co-factors
新型 HIV Rev 辅助因子的作用机制
- 批准号:
8843222 - 财政年份:2014
- 资助金额:
$ 178.53万 - 项目类别:
Mechanisms of Reactivation of Latent HIV by HDAC Inhibitors
HDAC 抑制剂重新激活潜伏 HIV 的机制
- 批准号:
8786930 - 财政年份:2014
- 资助金额:
$ 178.53万 - 项目类别:
Identification of novel co-factors for HIV Tat and Rev as therapeutic targets
鉴定 HIV Tat 和 Rev 的新辅助因子作为治疗靶点
- 批准号:
8505377 - 财政年份:2012
- 资助金额:
$ 178.53万 - 项目类别:
Identification of novel co-factors for HIV Tat and Rev as therapeutic targets
鉴定 HIV Tat 和 Rev 的新辅助因子作为治疗靶点
- 批准号:
8401302 - 财政年份:2012
- 资助金额:
$ 178.53万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 178.53万 - 项目类别:
Research Grant